ole-me-SAR-tan me-DOX-o-mil 
Therapeutic Classification: antihypertensives
Pharmacologic Classification: angiotensin II receptor antagonists
Absorption: Olmesartan medoxomil is a prodrug that is converted to olmesartan (the active component); 26% bioavailability of olmesartan.
Distribution: Crosses the placenta.
Protein Binding: 99%.
Metabolism/Excretion: No further metabolism following conversion of prodrug to active drug; 35–50% excreted unchanged in urine; remainder eliminated in feces via bile.
Half-life: 13 hr.
Contraindicated in:
Use Cautiously in:
CV: hypotension.
F and E: hyperkalemia.
GI: sprue-like enteropathy.
GU: impaired renal function.
Neuro: dizziness.
Misc: ANGIOEDEMA.
Drug-Drug:
(Generic available)
NDC Code*
